Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

Clinical trial NCT02153645 · TERMINATED

Trial details

NCT number: NCT02153645
Sponsor: Adamas Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease Levodopa Induced Dyskinesias (LID)

Start date: 2014-08-18
Primary completion: 2016-05-20
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.